DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Russell Boyce - 3 Oliver Taslic - 2 Synlab - 1 Cinven’s - 1 Cinven - 1 Sweden’s - 1 Dr Martens - 1 Elliott - 1
Top related locs:
Britain London Cinven France Dealogic Permira Synlab William Wright
Top related orgs:
REUTERS - 3 Thomson - 3 Revenue - 1 European Fine Chemicals Group - 1 Greenpeace - 1 Britain's Department for Energy Security - 1 Department for Energy Security - 1

Search resuls for: "Russell Boyce"


6 mentions found


☆ Private equity double-dips are a tasty faux pas
  + stars: | 2023-12-04 | by ( Aimee Donnellan | ) www.reuters.com   time to read: +3 min
Private equity groups are trying something similar in the capital markets: successfully listing a company, then coming back for a second bite by buying it back once its stock craters. Take Synlab (SYAB.DE), listed at the height of a Covid-19 boom in testing by investment group Cinven. European companies listed by private equity groups since 2020 are trading, on average, at a 22% discount to their IPO price, according to data from Dealogic and Breakingviews calculations. The message from such deals, however, is that it’s better to buy a private equity-owned company after it has listed. Follow @aimeedonnellan on XCONTEXT NEWSPrivate equity firm Cinven on Sept. 29 offered 10 euros a share to take Covid test maker Synlab private.
Persons: Russell Boyce, Synlab, Cinven’s, Cinven, Sweden’s, Dr Martens, Elliott, Neil Unmack, Oliver Taslic Organizations: REUTERS, Reuters, Revenue, Thomson Locations: London, Britain, Cinven, France, Dealogic, Permira, Synlab
☆ Drug shortages demand quick and costly action: podcast
  + stars: | 2023-11-07 | by ( Aimee Donnellan | ) www.reuters.com   time to read: 1 min
Used blister packets that contained medicines, tablets and pills are seen in this picture illustration taken June 30, 2018. In this Exchange podcast, Dr. Steffen Denzinger, president of the European Fine Chemicals Group, argues that safeguarding medicines may require patients to pay more. Listen to the podcastFollow @aimeedonnellan on XSubscribe to Breakingviews’ podcasts, Viewsroom and The Exchange. Editing by Oliver TaslicOur Standards: The Thomson Reuters Trust Principles. They do not reflect the views of Reuters News, which, under the Trust Principles, is committed to integrity, independence, and freedom from bias.
Persons: Russell Boyce, Steffen Denzinger, Oliver Taslic Organizations: REUTERS, Reuters, European Fine Chemicals Group, Thomson
☆ Greenpeace loses legal challenge to UK's new North Sea oil and gas licences
  + stars: | 2023-10-19 | by ( ) www.reuters.com   time to read: +2 min
Vessels that are used for towing oil rigs in the North Sea are moored up at William Wright docks in Hull, Britain November 2, 2017. REUTERS/Russell Boyce/File Photo Acquire Licensing RightsLONDON, Oct 19 (Reuters) - Britain's decision to authorise new licences for oil and gas exploration in the North Sea was lawful, London's High Court ruled on Thursday, dismissing a legal challenge by Greenpeace. Judge David Holgate rejected Greenpeace's case on Thursday, saying in a written ruling that the decision not to assess end-use emissions was not irrational. A Department for Energy Security and Net Zero spokesperson welcomed the decision. Britain says domestic oil and gas production is key to its plan to improve energy security and that doing so is consistent with its target of net zero carbon emissions by 2050.
Persons: William, Russell Boyce, David Holgate, Greenpeace's, Philip Evans, Tessa Khan, Sam Tobin, William James, Tomasz Janowski Organizations: REUTERS, Greenpeace, Britain's Department for Energy Security, Department for Energy Security, Thomson Locations: William Wright, Hull, Britain, North, Europe
☆ Explainer: After COVID and drug shortages, EU revamps drug laws
  + stars: | 2023-04-03 | by ( Maggie Fick | ) www.reuters.com   time to read: +5 min
The Commission aims to publish a draft - the biggest overhaul of existing medical laws in two decades - on April 26. A Commission spokesperson said: "The Commission will put forward a balanced and patient-centred proposal, whilst fully supporting an innovative and competitive industry." If the EU health regulator approves a new use for the medicine, they get another year, bringing the total to 11. Fourteen member states have written to the Commission, criticising the idea as costly and harmful for consumers as it could disrupt the generic drugs market. Once the Commission publishes the draft, the European Parliament, Commission and member states will thrash out final details.
☆ U.S. government to start imposing inflation penalties on drugmakers in 2025
  + stars: | 2023-02-09 | by ( ) www.reuters.com   time to read: +2 min
REUTERS/Russell Boyce/IllustrationWASHINGTON, Feb 9 (Reuters) - The U.S. government will begin imposing penalties in 2025 on drug companies that charge its Medicare program prices that rise faster than inflation, the Centers for Medicare & Medicaid Services said on Thursday. The agency issued initial guidance on how it will implement a provision in President Joe Biden's signature Inflation Reduction Act that penalizes drugmakers for raising prices faster than inflation. "The Medicare Prescription Drug Inflation Rebate Program will require drug companies with excessive increases in drug prices to pay rebates to Medicare," CMS Administrator Chiquita Brooks-LaSure said in a statement. Companies that raise prices higher than the inflation rate will be required to pay Medicare the difference in the form of a rebate. Price increases for half of all drugs covered by Medicare outpaced inflation from 2019 to 2020, which averaged 1% that year.
☆ FTSE 100 steady, midcaps fall ahead of key Fed meeting
  + stars: | 2022-11-02 | by ( Johann M Cherian | ) www.reuters.com   time to read: +2 min
UK pharmaceuticals stocks (.FTNMX201030) rose 1.2% after GSK (GSK.L) said it expects sales to rise between 8% and 10%, sending its shares up 1.2%. The blue-chip FTSE 100 (.FTSE) was flat, while the mid-cap FTSE 250 (.FTMC) fell 0.4% by 0934 GMT, dragged down by budget airline Wizz Air (WIZZ.L) after it said uncertainty for consumers rose. Third-quarter earnings among companies on the FTSE 100 have so far painted a mixed picture, as some firms performed better than expected as COVID restrictions eased globally, while some battled supply chain snags and surging inflation. British American Tobacco Plc fell 3%, to the bottom of FTSE 100, after Goldman Sachs downgraded its performance rating for the stock to "neutral". Reporting by Johann M Cherian in Bengaluru; Editing by Dhanya Ann Thoppil and Shailesh KuberOur Standards: The Thomson Reuters Trust Principles.
0 next >>
Total: 6